Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An enzyme with lipase and esterase activity was purified from bovine pancreas. Furthermore, a non-radioactive lipase assay was developed which is 100 times more sensitive than the conventional methods and allowed the characterization of the lipase activity of the enzyme. The lipase activity increased 42 times in the presence of 10 mM sodium taurocholate, which for the first time provides direct evidence that a bile salt-activated lipase (bp-
BAL
) was isolated from bovine pancreas. This conclusion is further supported by the fact that the N-terminal amino acid sequence of this lipase/esterase is 88% homologous to human milk
BAL
and human pancreatic
BAL
. Staining with various lectins showed that bp-
BAL
is a glycoprotein which contains fucose residues. Previously from bovine pancreas a lysophospholipase has been purified and a gene was cloned and sequenced encoding an enzyme with
cholesterol esterase
/lysophospholipase activity. Comparison of the N-terminal amino acid sequence of bp-
BAL
with the deduced amino acid sequence of the latter revealed that they are identical. Furthermore, the molecular weight of the purified bp-
BAL
of 63,000, as estimated by SDS-PAGE, is very similar to that of the purified lysophospholipase (65,000) and to the theoretical molecular weight of 65,147 of the
cholesterol esterase
/lysophospholipase. These data suggest that these three enzymes are one and the same.
...
PMID:Purification and characterization of bovine pancreatic bile salt-activated lipase. 1022 May 79